157 related articles for article (PubMed ID: 36198477)
21. Emergency department activities at the Athletes' Village during the Tokyo 2020 Olympic and Paralympic Games.
Kuroki N; Yagishita K; Shimizu K; Okuaki S; Doi Y; Arakawa Y; Nakano T; Akama T
Acute Med Surg; 2023; 10(1):e905. PubMed ID: 38020491
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 and Heat Illness in Tokyo, Japan: Implications for the Summer Olympic and Paralympic Games in 2021.
Shimizu K; Gilmour S; Mase H; Le PM; Teshima A; Sakamoto H; Nomura S
Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33807268
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 Infection upon Leaving the Tokyo 2020 Olympic and Paralympic Games.
Urashima M; Takao H; Sakano T; Takeshita K; Yoshida M; Nakazawa Y; Kawai M; Murayama Y
Intern Med; 2022 Dec; 61(24):3659-3666. PubMed ID: 36198605
[TBL] [Abstract][Full Text] [Related]
24. Head impact differences in blind football between Rio 2016 and Tokyo 2020 Paralympic Games: video-based observational study.
Tsutsumi S; Sasadai J; Maeda N; Tamura Y; Nagao T; Watanabe T; Arima S; Kaneda K; Yoshimi M; Mizuta R; Ishihara H; Shimizu R; Fukui K; Tashiro T; Komiya M; Suzuki A; Urabe Y
BMJ Open; 2024 Apr; 14(4):e081942. PubMed ID: 38569694
[TBL] [Abstract][Full Text] [Related]
25. "Time for Recovery" or "Utter Uncertainty"? The Postponement of the Tokyo 2020 Olympic Games Through the Eyes of Olympic Athletes and Coaches. A Qualitative Study.
Oblinger-Peters V; Krenn B
Front Psychol; 2020; 11():610856. PubMed ID: 33414751
[TBL] [Abstract][Full Text] [Related]
26. Did the Tokyo Olympic Games enhance the transmission of COVID-19? An interpretation with machine learning.
Hirata A; Kodera S; Diao Y; Rashed EA
Comput Biol Med; 2022 Jul; 146():105548. PubMed ID: 35537221
[TBL] [Abstract][Full Text] [Related]
27. Case study of the London 2012 Olympic and Paralympic pharmacy service preparations.
File H; Thomas T; Anderson G
Int J Pharm Pract; 2015 Jun; 23(3):212-20. PubMed ID: 25307524
[TBL] [Abstract][Full Text] [Related]
28. Doping control analyses during the Tokyo 2020 Olympic and Paralympic Games.
Okano M; Ikekita A; Sato M; Inoue T; Kageyama S; Akiyama K; Aoi A; Miyamoto A; Momobayashi A; Ota M; Ishige M; Sakurai H; Shiomura S; Takemine M; Watanabe Y; Hikota T
Drug Test Anal; 2022 Nov; 14(11-12):1836-1852. PubMed ID: 36208085
[TBL] [Abstract][Full Text] [Related]
29. Development and application of PyeongChang 2018 Winter Olympic and Paralympic Games Accessibility Manual.
Lee HL; Kim JY; Kim JB
Disabil Rehabil Assist Technol; 2021 May; 16(4):391-397. PubMed ID: 32419539
[TBL] [Abstract][Full Text] [Related]
30. Enhanced event-based surveillance for imported diseases during the Tokyo 2020 Olympic and Paralympic Games.
Kasamatsu A; Ota M; Shimada T; Fukusumi M; Yamagishi T; Samuel A; Nakashita M; Ukai T; Kurosawa K; Urakawa M; Takahashi K; Tsukada K; Futami A; Inoue H; Omori S; Kobayashi M; Komiya H; Shimada T; Tabata S; Yahata Y; Kamiya H; Yoshimatsu F; Sunagawa T; Saito T
Western Pac Surveill Response J; 2021; 12(4):1-7. PubMed ID: 35251745
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 infection during the Olympic and Paralympic Games Tokyo 2020.
Yashio T; Murayama A; Kami M; Ozaki A; Tanimoto T; Rodriguez-Morales AJ
Travel Med Infect Dis; 2021; 44():102205. PubMed ID: 34785374
[No Abstract] [Full Text] [Related]
32. Response to COVID-19 during the Tokyo Olympic Games: Did we properly assess the risk?
Jung SM; Hayashi K; Kayano T; Nishiura H
Epidemics; 2022 Sep; 40():100618. PubMed ID: 35908478
[TBL] [Abstract][Full Text] [Related]
33. Publics' Perceptions of Community Pharmacists and Satisfaction with Pharmacy Services in Al-Madinah City, Saudi Arabia: A Cross Sectional Study.
El-Kholy AA; Abdelaal K; Alqhtani H; Abdel-Wahab BA; Abdel-Latif MMM
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334609
[No Abstract] [Full Text] [Related]
34. A cross-sectional survey of the pharmacy workforce in general practice in Scotland.
Stewart D; Maclure K; Newham R; Gibson-Smith K; Bruce R; Cunningham S; Maclure A; Fry S; Mackerrow J; Bennie M
Fam Pract; 2020 Mar; 37(2):206-212. PubMed ID: 31536620
[TBL] [Abstract][Full Text] [Related]
35. A national analysis of the pharmacy workforce in Indonesia.
Meilianti S; Smith F; Kristianto F; Himawan R; Ernawati DK; Naya R; Bates I
Hum Resour Health; 2022 Sep; 20(1):71. PubMed ID: 36175892
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 Risk Assessment for the Tokyo Olympic Games.
Zhu W; Feng J; Li C; Wang H; Zhong Y; Zhou L; Zhang X; Zhang T
Front Public Health; 2021; 9():730611. PubMed ID: 34760863
[No Abstract] [Full Text] [Related]
37. Performance and thermoregulation of Dutch Olympic and Paralympic athletes exercising in the heat: Rationale and design of the Thermo Tokyo study: The journal
de Korte JQ; Bongers CCWG; Hopman MTE; Teunissen LPJ; Jansen KMB; Kingma BRM; Ballak SB; Maase K; Moen MH; van Dijk JW; Daanen HAM; Eijsvogels TMH
Temperature (Austin); 2021; 8(3):209-222. PubMed ID: 34485618
[TBL] [Abstract][Full Text] [Related]
38. Team USA COVID-19 Prevalence at Tokyo 2020 Summer Olympic and Paralympic Games.
Adams WM; Anderson T; Finnoff JT
Curr Sports Med Rep; 2023 Feb; 22(2):49-51. PubMed ID: 36757122
[No Abstract] [Full Text] [Related]
39. Corrigendum: Investigation of supplement use and knowledge among Japanese elite athletes for the Tokyo 2020 Olympic/Paralympic Games and the Beijing 2022 Winter Olympic/Paralympic Games.
Myoenzono K; Yasuda J; Takai E; Shinagawa A; Kaneko N; Yoshizaki T; Namma-Motonaga K; Yoshino M; Kondo E; Nakajima K; Hangai M; Kamahara K; Kamihigashi E; Kusano S; Kamei A
Front Sports Act Living; 2023; 5():1338039. PubMed ID: 38094085
[TBL] [Abstract][Full Text] [Related]
40. The impact of an emergency medicine clinical pharmacist on nursing satisfaction.
Treu CN; Llamzon JL; Acquisto NM; Lazar JD
Int J Clin Pharm; 2019 Dec; 41(6):1618-1624. PubMed ID: 31673851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
